A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer
Abstract At present, there is no validated marker to identify the subpopulation of patients with advanced gastric cancer (AGC) who might benefit from neoadjuvant chemotherapy (NACT). In view of this clinical challenge, the identification of non-invasive biomarkers for efficacy prediction of NACT in...
Main Authors: | Ting Guo, Xiao-Huan Tang, Xiang-Yu Gao, Yuan Zhou, Bo Jin, Zi-Qian Deng, Ying Hu, Xiao-Fang Xing, Zi-Yu Li, Jia-Fu Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-022-01684-9 |
Similar Items
-
Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis
by: Li Xue, et al.
Published: (2023-10-01) -
Autophagy-related lncRNAs and exosomal lncRNAs in colorectal cancer: focusing on lncRNA-targeted strategies
by: Yan Dong, et al.
Published: (2024-09-01) -
Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets
by: Xia Li, et al.
Published: (2024-12-01) -
Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer
by: Yuelei Zhao, et al.
Published: (2023-12-01) -
Identification of the key exosomal lncRNAs/mRNAs in the serum during distraction osteogenesis
by: Tao Zhang, et al.
Published: (2022-05-01)